药明巨诺-B
港股通 官网
( 02126.hk)
市盈率-1.11市净率1.11股息率0%上市时间2020-11-03股价1.65港币涨跌幅0.61%成交金额23.19万港币换手率0.03%市值6.88亿港币H股市值6.88亿港币总股本4.17亿H股本4.17亿每手股数500上市至今年化投资收益率-35.99%港股通持仓占H股比例8.43% (6,045.03万港币2026-07-21)
所属三级行业生物技术 (恒生) 市盈率122.29市净率4.46股息率0.37%恒生:医疗保健业药品及生物科技生物技术
备注 (3): 双击编辑备注
发表讨论

药明巨诺-B(02126) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1LEE Li AnnIndependent Non Executive Director2023-08-29--
2SONG Sung WonNon Executive Director2023-08-29--
3VISWANADHAN KrishnanIndependent Non Executive Director2023-08-29--
4余久筠Independent Non Executive Director2023-03-01--
5張耀樑Independent Non Executive Director - A/F2020-10-22--
6何建昌Independent Non Executive Director - A/F2020-10-22--
7李志成Independent Non Executive Director2020-10-222023-01-01
8劉誠Non Executive Director2020-06-30--
9高星Non Executive Director2020-05-22--
10LEE Li AnnNon Executive Director2020-05-222023-08-29
11王金印Non Executive Director2020-05-222023-08-29
12曹彥凌Independent Non Executive Director2020-05-222021-12-03
13VISWANADHAN KrishnanNon Executive Director2019-11-202023-08-29
14李怡平Executive DirectorChairman, CEO2017-11-14--
15BISHOP Hans EdgarNon Executive Director2017-11-142021-12-03